Prot #BAY1841788/17777: A Randomized, Double-Blind, Placebo-Controlled Phase III Study of ODM-201 Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients with Metastatic Hormone-Sensitive Prostate Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date5/16/174/1/24

Funding

  • Covance Inc. (Prot #BAY1841788/17777)
  • Bayer HealthCare Pharmaceuticals, Inc. (Prot #BAY1841788/17777)